Campbell TB - Search Results

1

Risk factors for falls in HIV-infected persons.

Erlandson KM, Allshouse AA, Jankowski CM, Duong S, MaWhinney S, Kohrt WM, Campbell TB. Erlandson KM, et al. Among authors: campbell tb. J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):484-9. doi: 10.1097/QAI.0b013e3182716e38. J Acquir Immune Defic Syndr. 2012. PMID: 23143526 Free PMC article.

2

Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection.

Campbell TB, Fitzpatrick L, MaWhinney S, Zhang X, Schooley RT. Campbell TB, et al. J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):333-40. doi: 10.1097/00126334-199912010-00003. J Acquir Immune Defic Syndr. 1999. PMID: 10634194

3

Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage.

Campbell TB, Borok M, Gwanzura L, MaWhinney S, White IE, Ndemera B, Gudza I, Fitzpatrick L, Schooley RT. Campbell TB, et al. AIDS. 2000 Sep 29;14(14):2109-16. doi: 10.1097/00002030-200009290-00006. AIDS. 2000. PMID: 11061651

4

Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.

Connick E, Schlichtemeier RL, Purner MB, Schneider KM, Anderson DM, MaWhinney S, Campbell TB, Kuritzkes DR, Douglas JM Jr, Judson FN, Schooley RT. Connick E, et al. Among authors: campbell tb. J Infect Dis. 2001 Dec 1;184(11):1465-9. doi: 10.1086/324488. Epub 2001 Nov 13. J Infect Dis. 2001. PMID: 11709791

5

Challenges in the study of patients with HIV type 1 seroconversion.

Connick E, MaWhinney S, Wilson CC, Campbell TB. Connick E, et al. Among authors: campbell tb. Clin Infect Dis. 2005 May 1;40(9):1355-7. doi: 10.1086/429339. Epub 2005 Mar 31. Clin Infect Dis. 2005. PMID: 15825039 No abstract available.

6

Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection.

Campbell TB, Shulman NS, Johnson SC, Zolopa AR, Young RK, Bushman L, Fletcher CV, Lanier ER, Merigan TC, Kuritzkes DR. Campbell TB, et al. Clin Infect Dis. 2005 Jul 15;41(2):236-42. doi: 10.1086/430709. Epub 2005 Jun 7. Clin Infect Dis. 2005. PMID: 15983922

7

HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia.

Koeppe JR, Campbell TB, Rapaport EL, Wilson CC. Koeppe JR, et al. Among authors: campbell tb. J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):140-8. doi: 10.1097/01.qai.0000195608.32885.38. J Acquir Immune Defic Syndr. 2006. PMID: 16394844

8

Gender differences in AIDS-associated Kaposi sarcoma in Harare, Zimbabwe.

Meditz AL, Borok M, MaWhinney S, Gudza I, Ndemera B, Gwanzura L, Campbell TB. Meditz AL, et al. Among authors: campbell tb. J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):306-8. doi: 10.1097/QAI.0b013e31802c83d9. J Acquir Immune Defic Syndr. 2007. PMID: 17146369

9

Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe.

Campbell TB, Borok M, Ndemera B, Fiorillo S, White IE, Zhang XQ, Machekano RN, Katzenstein D, Gwanzura L. Campbell TB, et al. Clin Infect Dis. 2009 Jun 1;48(11):1601-8. doi: 10.1086/598978. Clin Infect Dis. 2009. PMID: 19400749 Free PMC article.

10

Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.

Letang E, Almeida JM, Miró JM, Ayala E, White IE, Carrilho C, Bastos R, Nhampossa T, Menéndez C, Campbell TB, Alonso PL, Naniche D. Letang E, et al. Among authors: campbell tb. J Acquir Immune Defic Syndr. 2010 Apr;53(5):589-97. doi: 10.1097/QAI.0b013e3181bc476f. J Acquir Immune Defic Syndr. 2010. PMID: 19801945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters